MAPT and Cognitive impairment: Moreover, inhibition of microRNA-146a expression with antagomir not only reverses the protein levels and/or phosphorylation of crucial signaling pathway elements (ROCK1-PTEN-Tau) in the brain, but also partly attenuates associated cognitive impairment.